Cargando…

A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data

In several neurodegenerative diseases, like Huntington's disease (HD), treatments are still lacking. To determine whether a treatment is effective, sensitive disease progression biomarkers are especially needed for the premanifest phase, since this allows the evaluation of neuroprotective treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beste, Christian, Stock, Ann-Kathrin, Ness, Vanessa, Hoffmann, Rainer, Lukas, Carsten, Saft, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647202/ https://www.ncbi.nlm.nih.gov/pubmed/23652721 http://dx.doi.org/10.1038/srep01797

Ejemplares similares

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
por: Schmid, Rahel Dominique, et al.
Publicado: (2022)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Striatal disorders dissociate mechanisms of enhanced and impaired response selection — Evidence from cognitive neurophysiology and computational modelling
por: Beste, Christian, et al.
Publicado: (2014)

Testing a longitudinal compensation model in premanifest Huntington’s disease
por: Gregory, Sarah, et al.
Publicado: (2018)

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
por: Stout, Julie C, et al.
Publicado: (2012)

Resting-state connectivity stratifies premanifest Huntington’s disease by longitudinal cognitive decline rate
por: Polosecki, Pablo, et al.
Publicado: (2020)

Music perception and movement deterioration in Huntington’s disease
por: Beste, Christian, et al.
Publicado: (2011)

Magnetization transfer imaging in ‘premanifest’ Huntington’s disease
por: Jurgens, Caroline K., et al.
Publicado: (2009)

Error Processing in Huntington's Disease
por: Beste, Christian, et al.
Publicado: (2006)

On the Neurophysiological Mechanisms Underlying the Adaptability to Varying Cognitive Control Demands
por: Zink, Nicolas, et al.
Publicado: (2018)

Sleep deficits but no metabolic deficits in premanifest Huntington's disease
por: Lazar, Alpar S., et al.
Publicado: (2015)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Cruickshank, Travis, et al.
Publicado: (2021)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
por: Jurgens, Caroline K, et al.
Publicado: (2010)

White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice
por: Winder, Jessica Y., et al.
Publicado: (2018)

In vivo characterization of white matter pathology in premanifest huntington's disease
por: Zhang, Jiaying, et al.
Publicado: (2018)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019)

Time Processing in Huntington's Disease: A Group-Control Study
por: Beste, Christian, et al.
Publicado: (2007)

Neurophysiological mechanisms of circadian cognitive control in RLS patients - an EEG source localization study
por: Zhang, Rui, et al.
Publicado: (2017)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease
por: Hart, Ellen, et al.
Publicado: (2011)

Abnormal Electrophysiological Motor Responses in Huntington’s Disease: Evidence of Premanifest Compensation
por: Turner, Lauren M., et al.
Publicado: (2015)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021)

Altered third‐party punishment in Huntington's disease: A study using neuroeconomic games
por: Brüne, Martin, et al.
Publicado: (2020)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
por: Faria, Andreia V., et al.
Publicado: (2016)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
por: Castro, Eduardo, et al.
Publicado: (2018)

Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
por: Zeun, Paul, et al.
Publicado: (2022)

Neurophysiological mechanisms underlying the differential effect of reward prospect on response selection and inhibition
por: Koyun, Anna Helin, et al.
Publicado: (2023)

Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort
por: Achenbach, Jannis, et al.
Publicado: (2021)

Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease
por: Rusz, Jan, et al.
Publicado: (2014)

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
por: Paulsen, Jane S., et al.
Publicado: (2014)

Multi-Modal Neuroimaging in Premanifest and Early Huntington’s Disease: 18 Month Longitudinal Data from the IMAGE-HD Study
por: Domínguez D, Juan F., et al.
Publicado: (2013)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
por: Goodman, Anna O. G., et al.
Publicado: (2011)

Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington’s Disease
por: Collins, Lucy M., et al.
Publicado: (2015)

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017)

The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington’s disease individuals
por: Júlio, Filipa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k6lot8k8sqdpkm6tlb0i7tc6ek